Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FATHT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,893
Award facts
- Contract value 100% obligated
- $1,892.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,892.90 to DMS Pharmaceutical Group Inc. for NUCALA 100 mg/ml auto-injector on September 10, 2025. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, a $500 million vehicle that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities. NUCALA is a biologic medication used for managing severe eosinophilic asthma and other conditions, supplied in auto-injector format for convenient patient administration. The delivery order carries an ultimate completion date of September 11, 2025, with performance occurring at the vendor's location in Park Ridge, Illinois. No set-aside designation was applied to this award.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has established itself as a critical supplier within the federal pharmaceutical supply chain. The company leverages its competitive position and extensive federal procurement experience to deliver branded and generic prescription drugs, biologics, and specialized medical consumables to military and federal healthcare systems nationwide. With consistent contract awards from the DLA since its SAM.gov registration in 2001, DMS Pharmaceutical Group demonstrates the operational capability and compliance standards necessary to support DoD medical supply requirements across multiple product categories and facility locations.
Quick answers
Who was awarded contract SPE2DB25FATHT?
SPE2DB25FATHT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FATHT worth?
The government has obligated $1,893 on SPE2DB25FATHT.
Is contract SPE2DB25FATHT an order under another contract?
Yes. SPE2DB25FATHT is a delivery order under SPE2DB24D9228, an indefinite delivery contract.
Was contract SPE2DB25FATHT competed?
The extent of competition for SPE2DB25FATHT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award